These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 7740416)

  • 21. Patterns of failure in children with medulloblastoma: effects of preirradiation chemotherapy.
    Hartsell WF; Gajjar A; Heideman RL; Langston JA; Sanford RA; Walter A; Jones D; Chen G; Kun LE
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):15-24. PubMed ID: 9300735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An audit of craniospinal irradiation for medulloblastoma in Newcastle 1970-1992.
    Tinkler D; Lucraft HH
    Clin Oncol (R Coll Radiol); 1995; 7(3):179-83. PubMed ID: 7547521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complete response after treatment with a somatostatin analogue in an adult patient with recurrent medulloblastoma.
    Glas M; Hennemann B; Hirschmann B; Marienhagen J; Schmidt-Wolf I; Herrlinger U; Bogdahn U; Hau P
    Acta Oncol; 2008; 47(3):479-80. PubMed ID: 17934891
    [No Abstract]   [Full Text] [Related]  

  • 24. Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy.
    Jimenez RB; Sethi R; Depauw N; Pulsifer MB; Adams J; McBride SM; Ebb D; Fullerton BC; Tarbell NJ; Yock TI; Macdonald SM
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):120-6. PubMed ID: 23790826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy.
    Taylor RE; Bailey CC; Robinson KJ; Weston CL; Walker DA; Ellison D; Ironside J; Pizer BL; Lashford LS
    Eur J Cancer; 2005 Mar; 41(5):727-34. PubMed ID: 15763649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters.
    von Bueren AO; Kortmann RD; von Hoff K; Friedrich C; Mynarek M; Müller K; Goschzik T; Zur Mühlen A; Gerber N; Warmuth-Metz M; Soerensen N; Deinlein F; Benesch M; Zwiener I; Kwiecien R; Faldum A; Bode U; Fleischhack G; Hovestadt V; Kool M; Jones D; Northcott P; Kuehl J; Pfister S; Pietsch T; Rutkowski S
    J Clin Oncol; 2016 Dec; 34(34):4151-4160. PubMed ID: 27863192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Well differentiated astrocytoma occurring nine years after radiation therapy for medulloblastoma.
    Osumi AK; Mclendon RE; Tien RD; Friedman HS; Graham M; Hockenberger B; Halperin EC; Oakes WJ
    Clin Neuropathol; 1994; 13(5):281-5. PubMed ID: 7805312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of medulloblastoma and ependymoma in infants: a single-institution long-term retrospective report.
    Massimino M; Gandola L; Cefalo G; Lasio G; Riva D; Fossati-Bellani F; Gianni MC; Luksch R; Tesoro-Tess JD; Lombardi F
    Childs Nerv Syst; 2000 Jan; 16(1):15-20. PubMed ID: 10672424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma?
    Dupuis-Girod S; Hartmann O; Benhamou E; Doz F; Mechinaud F; Bouffet E; Coze C; Kalifa C
    J Neurooncol; 1996 Jan; 27(1):87-98. PubMed ID: 8699230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-pineal supratentorial primitive neuro-ectodermal tumors (sPNET) in teenagers and young adults: Time to reconsider cisplatin based chemotherapy after cranio-spinal irradiation?
    Biswas S; Burke A; Cherian S; Williams D; Nicholson J; Horan G; Jefferies S; Williams M; Earl HM; Burnet NG; Hatcher H
    Pediatr Blood Cancer; 2009 Jul; 52(7):796-803. PubMed ID: 19202566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
    Packer RJ; Gajjar A; Vezina G; Rorke-Adams L; Burger PC; Robertson PL; Bayer L; LaFond D; Donahue BR; Marymont MH; Muraszko K; Langston J; Sposto R
    J Clin Oncol; 2006 Sep; 24(25):4202-8. PubMed ID: 16943538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multivariate survival analysis of children with medulloblastoma--a single-center experience.
    Chen SH; Liu LY; Jaing TH; Tseng CK; Lin KL; Lui TN
    Pediatr Hematol Oncol; 2008 Sep; 25(7):647-54. PubMed ID: 18850477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma.
    Taylor RE; Bailey CC; Robinson KJ; Weston CL; Ellison D; Ironside J; Lucraft H; Gilbertson R; Tait DM; Saran F; Walker DA; Pizer BL; Lashford LS; ;
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1184-93. PubMed ID: 15001263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiation and chemotherapy in pediatric infratentorial tumors.
    Mastrangelo R; Marmiroli L; Tornesello MA; Ausili-Cefaro G
    Rays; 1993; 18(4):471-85. PubMed ID: 8047664
    [No Abstract]   [Full Text] [Related]  

  • 35. Radiotherapeutic management of medulloblastoma.
    Paulino AC
    Oncology (Williston Park); 1997 Jun; 11(6):813-23; discussion 823, 827-8, 831. PubMed ID: 9189939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pre-irradiation chemotherapy in high risk medulloblastoma.
    Abd-El-Aal HH
    J Egypt Natl Canc Inst; 2006 Dec; 18(4):357-62. PubMed ID: 18301459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longterm treatment results of childhood medulloblastoma by craniospinal irradiation in supine position.
    Slampa P; Pavelka Z; Dusek L; Hynkova L; Sterba J; Ondrova B; Princ D; Novotny T; Kostakova S
    Neoplasma; 2007; 54(1):62-7. PubMed ID: 17203894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of high-dose chemotherapy and stem cell rescue in the treatment of malignant brain tumors.
    Finlay JL
    Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S1-5. PubMed ID: 8971398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ovarian function in survivors of childhood medulloblastoma: Impact of reduced dose craniospinal irradiation and high-dose chemotherapy with autologous stem cell rescue.
    Balachandar S; Dunkel IJ; Khakoo Y; Wolden S; Allen J; Sklar CA
    Pediatr Blood Cancer; 2015 Feb; 62(2):317-321. PubMed ID: 25346052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multivariate analysis of dissemination relapse of medulloblastoma and estimation of its time parameter for craniospinal irradiation.
    Inakoshi H; Kayamori R; Tsuchida E; Sakai K; Shibamoto Y; Wakushima H; Ogawa Y; Kobayashi M; Obara T
    Radiat Med; 2003; 21(1):37-45. PubMed ID: 12801142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.